LAS VEGAS, Oct. 16, 2015 /PRNewswire/ — DigiPath Labs, a subsidiary of DigiPath, Inc. (OTCBB: DIGP), recently joined the Association of Commercial Cannabis Laboratories (“ACCL”), a group of independent lab operators that have come together to address the lack of standards and standard practices in the medical and recreational cannabis industry in the United States. “By joining the ACCL, DigiPath Labs further demonstrates its adherence to strict testing guidelines and commitment to quality assurance for marijuana consumers in Nevada,” commented Dr. Cindy Orser, DigiPath Labs’ Chief Scientific Officer.
Founded in 2011, the ACCL and its member organizations are dedicated to establishing medical marijuana best practices and certifications for quality standards. Since its inception, the ACCL has been at the forefront of the movement to develop mandatory testing protocols for medicinal marijuana products, with the expansion of its membership base to include cannabis-testing laboratories throughout North America. The organization continues to serve as an example to the rest of the industry on how to work together effectively to bring greater legitimacy and credibility to the medical marijuana community.
As a member of ACCL, DigiPath Labs adheres to the association’s tenets of integrity, proficiency, reliability, credibility, establishing and maintaining a QC/QA program, and accountability. Unique to the ACCL are the additional requirements for members to conduct themselves professionally in an effort to increase the integrity of the cannabis testing industry and to advance the scientific understanding of cannabis to the general public in a continuing effort to push back the frontiers of ignorance surrounding cannabis.
Furthermore, the ACCL strongly recommends that all members obtain ISO certification. Consistent with the ACCL’s recommendation, DigiPath Labs recently initiated the process of seeking ISO 17025 accreditation. Both membership in the ACCL and the path toward ISO accreditation place DigiPath Labs amongst the highest quality cannabis testing labs in the country.
Todd Denkin, CEO of DigiPath Labs, stated, “ISO accreditation means that medical marijuana cultivators, producers and patients can be confident that required test results are compliant with state laws and that good laboratory practices are consistent with other industries.”
To learn more about DigiPath Labs, visit www.digipathlabs.com.
About DigiPath, Inc.
DigiPath, Inc., supports the cannabis industry’s best practices for reliable testing, education, and training, and brings unbiased cannabis news coverage to the nation. DigiPath’s two business units are DigiPath Labs and TNM News Corp.
For more information, go to www.digipath.com.
Information about Forward-Looking Statements
This press release contains “forward-looking statements” that include information relating to future events, and future financial and operating performance. Forward-looking statements should not be read as a guarantee of future performance or results, and will not necessarily be accurate indications of the times at, or by, which that performance or those results will be achieved. Forward-looking statements are based on information available at the time they are made and/or management’s good faith belief as of that time with respect to future events, and are subject to risks and uncertainties that could cause actual performance or results to differ materially from those expressed in, or suggested by, the forward-looking statements. Important factors that could cause these differences include, but are not limited to: the demand for the Company’s products, the introduction of new products, the Company’s ability to maintain customer and strategic business relationships, the impact of competitive products and pricing, growth in targeted markets, the adequacy of the Company’s liquidity and financial strength to support its growth, and other information that may be detailed from time-to-time in the Company’s filings with the United States Securities and Exchange Commission. For a more detailed description of the risk factors and uncertainties affecting DigiPath, please refer to the Company’s recent Securities and Exchange Commission filings, which are available at www.sec.gov. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise.